|
|
||||||||
Institut National de la Santé et de la Recherche Médicale Unité 1 499 and 2 449, Faculté RTH Laennec, 69008 Lyon, France; and 3 Centre de Recherche en Nutrition Humaine, Hôpital E. Herriot, 69003 Lyon, France
To determine whether increased lipogenesis contributes to human obesity, we measured (postabsorptive state), in lean and obese subjects, lipid synthesis (deuterated water method) and the mRNA concentration (RT-competitive PCR) in subcutaneous adipose tissue of fatty acid synthase (FAS) and sterol regulatory element-binding protein (SREBP)-1c. Before energy restriction, obese subjects had an increased contribution of hepatic lipogenesis to the circulating triglyceride pool (14.5 ± 1.3 vs. 7.5 ± 1.9%, P < 0.01) without enhancement of cholesterol synthesis. This increased hepatic lipogenesis represented an excess of 2-5 g/day of triglycerides, which would represent 0.7-1.8 kg on a yearly basis. The lipogenic capacity of adipose tissue appeared, on the contrary, decreased with lower FAS mRNA levels (P < 0.01) and a trend for decreased SREBP-1c mRNA (P = 0.06). Energy restriction in obese patients decreased plama insulin (P < 0.05) and leptin (P < 0.05) and normalized hepatic lipogenesis. FAS mRNA levels were unchanged, whereas SREBP-1c increased. In conclusion, subjects with established obesity have an increased hepatic lipogenesis that could contribute to their excessive fat mass but no evidence for an increased lipogenic capacity of adipose tissue.
fatty acid synthase; sterol regulatory element-binding protein-1c; stable isotope; messenger ribonucleic acid; lipids
This article has been cited by other articles:
![]() |
C. Beysen, E. J. Murphy, H. Nagaraja, M. Decaris, T. Riiff, A. Fong, M. K. Hellerstein, and P. J. Boyle A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes J. Lipid Res., December 1, 2008; 49(12): 2657 - 2663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefanovic-Racic, G. Perdomo, B. S. Mantell, I. J. Sipula, N. F. Brown, and R. M. O'Doherty A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E969 - E977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F-F Chong, L. Hodson, A. S Bickerton, R. Roberts, M. Neville, F. Karpe, K. N Frayn, and B. A Fielding Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding Am. J. Clinical Nutrition, April 1, 2008; 87(4): 817 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Ryan, F. Abbasi, C. Lamendola, S. Carter, and T. L. McLaughlin Serum Alanine Aminotransferase Levels Decrease Further With Carbohydrate Than Fat Restriction in Insulin-Resistant Adults Diabetes Care, May 1, 2007; 30(5): 1075 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Turner, S. Roy, H. S. Sul, R. A. Neese, E. J. Murphy, W. Samandi, D. J. Roohk, and M. K. Hellerstein Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1101 - E1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Parkes, E. Preston, D. Wilks, M. Ballesteros, L. Carpenter, L. Wood, E. W. Kraegen, S. M. Furler, and G. J. Cooney Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E737 - E744. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shiwaku, M. Hashimoto, K. Kitajima, A. Nogi, E. Anuurad, B. Enkhmaa, J.-M. Kim, I.-S. Kim, S.-K. Lee, T. Oyunsuren, et al. Triglyceride levels are ethnic-specifically associated with an index of stearoyl-CoA desaturase activity and n-3 PUFA levels in Asians J. Lipid Res., May 1, 2004; 45(5): 914 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Diraison, V. Yankah, D. Letexier, E. Dusserre, P. Jones, and M. Beylot Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans J. Lipid Res., April 1, 2003; 44(4): 846 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Letexier, F. Diraison, and M. Beylot Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans Am. J. Clinical Nutrition, March 1, 2003; 77(3): 559 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lan, M. E. Rabaglia, J. P. Stoehr, S. T. Nadler, K. L. Schueler, F. Zou, B. S. Yandell, and A. D. Attie Gene Expression Profiles of Nondiabetic and Diabetic Obese Mice Suggest a Role of Hepatic Lipogenic Capacity in Diabetes Susceptibility Diabetes, March 1, 2003; 52(3): 688 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Attie, R. M. Krauss, M. P. Gray-Keller, A. Brownlie, M. Miyazaki, J. J. Kastelein, A. J. Lusis, A. F. H. Stalenhoef, J. P. Stoehr, M. R. Hayden, et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia J. Lipid Res., November 1, 2002; 43(11): 1899 - 1907. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |